The feasibility of multimodal fiber optic spectroscopy analysis in bladder cancer detection, grading, and staging

Year: 2021

Authors: Morselli S., Baria E., Cicchi R., Liaci A., Sebastianelli A., Nesi G., Serni S., Pavone FS., Gacci M.

Autors Affiliation: Careggi Univ Hosp, Unit Minimally Invas & Robot Urol Surg & Kidney T, Florence, Italy; Univ Florence, Dept Expt & Clin Med, Florence, Italy; Univ Florence, European Lab Non Linear Spect, Sesto Fiorentino, Italy; CNR, Natl Inst Opt, Sesto Fiorentino, Italy; Univ Florence, Div Pathol Anat, Dept Clin & Expt Med, Florence, Italy; Univ Florence, Dept Phys & Astron, Sesto Fiorentino, Italy.

Abstract: Objective: To prove the feasibility of Multimodal Fiber Optic Spectroscopy (MFOS) analysis in bladder cancer (BCa) detection, grading, and staging. Materials and methods: Bladder specimens from patients underwent TURBT or TURP were recorded and analyzed with MFOS within 30 min from excision. In detail, our MFOS combined fluorescence, Raman spectroscopy, and diffuse reflectance. We used these optical techniques to collect spectra from bladder biopsies, then we compared the obtained results to gold standard pathological analysis. Finally, we developed a classification algorithm based on principal component analysis-linear discriminant analysis. Results: A total of 169 specimens were collected and analyzed from 114 patients, 40 (23.7%) healthy (from TURP), and 129 (76.3%) with BCa. BCa specimens were divided according to their grade-34 (26.4%) low grade (LG) and 95 (73.6%) high grade (HG) BCa-and stage-64 (49.6%) Ta, 45 (34.9%) T1, and 20 (15.5%) T2. MFOS-based classification algorithm correctly discriminated healthy versus BCa with 90% accuracy, HG versus LG with 83% accuracy. Furthermore, it assessed tumor stage with 75% accuracy for Ta versus T1, 85% for T1 versus T2, and 86% for Ta versus T2. Conclusions: Our preliminary results suggest that MFOS could be a reliable, fast, and label-free tool for BCa assessment, providing also grading and staging information. This technique could be applied in future for in vivo inspection as well as of ex vivo tissue biopsies. Thus, MFOS might improve urothelial cancer management. Further studies are required.

Journal/Review: UROLOGIA JOURNAL

Volume: 88 (4)      Pages from: 3.9156032110070  to: 3.9156032110070

KeyWords: Bladder cancer; spectroscopy; grading; staging; diagnosis; pathology; bladder; urothelial cancer
DOI: 10.1177/03915603211007018

Citations: 3
data from “WEB OF SCIENCE” (of Thomson Reuters) are update at: 2024-11-17
References taken from IsiWeb of Knowledge: (subscribers only)
Connecting to view paper tab on IsiWeb: Click here
Connecting to view citations from IsiWeb: Click here